  Vaccine effectiveness (VE) is typically defined as incidence rate ratio,
cumulative-risk ratio, or odds ratio. The VE based on incidence rate ratio is
known to be time-invariant over the study period for leaky action vaccines and,
the VE based on cumulative-risk ratio is time-invariant for all-or-none action
vaccines. Consequently, these VE measures are recommended as appropriate
measures of VE for leaky and all-or-none vaccines, respectively. However, in
diseases with multiple pathogen variants and multiple vaccines, investigators
may also be interested in variant-specific VE of a vaccine, the relative VE of
a vaccine against two variants, or the relative VE of different vaccines
against a given variant. In this multi-variant and multi-vaccine scenario, the
temporal properties of the aforementioned VE measures have not been studied
entirely yet. Furthermore, no general-purpose sample size calculator is
available for either studies that intend to estimate variant-specific VE or
relative VE. As a solution, we define variant-specific and relative VE measures
while accounting for multiple competing pathogen variants. We then propose a
generic mode of action for all-or-none vaccines in a multi-variant setting.
Subsequently, we evaluate the conditions and the extent to which various VE
measures can be time-varying. We show that every VE measure is time-varying for
all-or-none action vaccines in a multi-variant and multi-vaccine scenario. For
leaky vaccines, we show that all measures other than those based on incidence
rate ratios are time-varying. We discuss the practical implications of these
results on VE studies in the context of the commonly used cohort, cumulative
case-control, and test-negative study designs. Lastly, for the multi-variant
and multi-vaccine scenario, we implement sample size calculations for both
variant-specific and relative VE in an R package and an online calculator.
